COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and … between IP, innovation, access, and public health between stakeholders with divergent interests. This working paper provides …

(SEPs), and the patent policies of standards development organizations (SDOs). While this litigation has fueled a cottage …

. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …

innovative medicines in those markets? (2) For launched new and innovative medicines, how much do patent owners or generic … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood … pharmaceuticals are launched sooner than non-innovative ones, irrespective of the patent regime in the local market. Using a panel …